Receiving a cancer diagnosis can be a life-altering moment that leaves you feeling overwhelmed and fearful. Victor Gonzalez, a senior director at The Lymphoma Research Foundation, has firsthand experience dealing with the impact of a blood cancer diagnosis, both professionally and personally. Watching his mother battle aggressive stomach cancer and facing his own diagnosis of Barrett’s esophagus has given him a unique perspective on the emotions that come with such news.
In his work with lymphoma and leukemia patients, Gonzalez has witnessed the wide range of reactions that can follow a cancer diagnosis, particularly chronic lymphocytic leukemia (CLL). He understands the shock and paralysis that can accompany such news, but emphasizes the importance of seeking information and finding hope in the stories of others who have gone through similar experiences.
While each CLL journey is unique, Gonzalez highlights key milestones that can provide a sense of progress and resilience during treatment. From focusing on meaningful events in your life to exploring new opportunities for personal growth, he encourages patients to stay positive and proactive in their care.
One significant development in CLL treatment is the expansion of therapeutic options beyond traditional chemotherapy. BCL-2 inhibitors like VENCLEXTA offer a promising alternative by targeting specific proteins that fuel cancer growth. Gonzalez believes that staying informed about treatment options, such as the chemo-free regimen of VENCLEXTA plus GAZYVA, can empower patients to take an active role in their health.
It’s important to note that VENCLEXTA, while offering potential benefits, can also pose serious risks like tumor lysis syndrome. Patients should discuss their medical history and any concerns with their healthcare provider before starting treatment. By staying informed and engaged in their care, CLL patients can navigate their journey with knowledge and confidence.
